HopeStage
Back to all studies
WithdrawnNCT02004171

Electronic Cigarettes or Nicotine Inhaler for Smoking Cessation

Medication studyAges 18–60United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 60 years.

Listed locations
New YorkSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateDecember 2013
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
New York State Psychiatric Institute
Sponsor type
Research institute
Study type
Drug
Intervention type
Medication / drug, OTHER
Study phase
Not clearly listed
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT02004171
Official title
Show the full official title

Electronic Nicotine Delivery Devices (ENDDs) or Nicotine Inhaler for Smoking Cessation

Recruitment & locations

Withdrawn

New York

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is New York State Psychiatric Institute, a research institute.

Does this study involve medication?

Yes. The study involves medication, including nicotine inhaler.

Who can participate?

Listed age limits: 18 years to 60 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies